July 13, 2021

Bioshares Interview: Malcolm McColl, CEO ImmVirX

Bioshares recently interviewed our CEO Malcolm McColl as part of their latest edition.
‍

You can read the full story in PDF format here.
‍
‍

Tags:

Continue reading

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

May 19, 2021

by

ImmVirX raising $25m led by renowned healthcare VC OneVentures

Company Announcements

May 19, 2021

by

ImmVirX enters the clinic with next generation oncolytic virus

Company Announcements

May 19, 2021

by

Dr Malcolm McColl

ImmVirX enters the clinic with next generation oncolytic virus

Company Announcements

May 19, 2021

by

Dr Malcolm McColl

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

May 19, 2021

by

ImmVirX receives $2.81M R&D tax refund for FY22

Company Announcements

May 19, 2021

by

Join Our Mailing List

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect